Kewaunee Scientific Corporation
NASDAQ:KEQUFurnishings, Fixtures & Appliances
-$0.41 today
- Market cap
- $100.35M
- Beta
- 0.69
- P/E (TTM)
- 9.6
- EPS (TTM)
- $3.87
Volume 0.00M
Average 0.00M
KEQU EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Kewaunee Scientific CorporationNASDAQ: KEQU
EBITDA · Q3 FY2026 · quarter ended Jan 2026
EBITDA grows, but more slowly than its trailing trend
Q3 FY2026 EBITDA of $4.18M rose 5.1% year over year, behind the +75.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 31.4% from the prior quarter. Over 3 fiscal years it compounded at +191.8% a year.
Context
- EBITDA amounted to 9.5% of revenue in FY2025, up 0.6 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $16.19M (-28.9%) for the fiscal year ending Apr 2026, a slowdown from the +26.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJan 2026
- $4.18M-31.4% QoQ
- Last fiscal yearApr 2025
- $22.76M+26.1% YoY
- LTMJan 2026
- $26.69M+75.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.1% | — | — |
| 1 year | +26.1% | -28.9% | -55.0 pp |
| 3-year CAGR | +191.8% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 22.76M USD
- Year-over-year change
- +26.1%
- 4-year CAGR
- +165.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-04-30 | 22.76M | +26.1% |
| FY2024 | 2024-04-30 | 18.04M | +121.1% |
| FY2023 | 2023-04-30 | 8.16M | +790.8% |
| FY2022 | 2022-04-30 | 916K | +99.6% |
| FY2021 | 2021-04-30 | 459K | — |
EBITDA vs competitors
How KEQU compares with its peers on the latest reported figures
- KEQU's LTM Jan 2026 EBITDA of $26.69M is the 2nd highest of the 8 companies compared; the peer median is $8.27M.
- Its year-over-year change of +75.6% is the 4th highest of 8, against a peer median of +7.9%.
- EBITDA amounts to 9.3% of revenue for KEQU, versus a peer median of 6.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $71.37M | +7.9% | +15.9% | 9.3% | |
| LTM Jan 2026 | $26.69M | +75.6% | +191.8% | 9.3% | |
| LTM Feb 2026 | $17.97M | +24851.4% | -26.4% | 5.4% | |
| LTM Mar 2026 | $8.47M | +174.6% | — | 15.9% | |
| LTM Mar 2026 | $8.27M | +152.2% | — | 6.8% | |
| LTM Apr 2026 | $5.52M | -83.3% | -12.1% | 2.8% | |
| LTM May 2026 | -$12.64M | -158.1% | — | 4.4% | |
| LTM Mar 2026 | -$45.37M | -215.1% | — | 8.9% | |
| Peer median (excluding KEQU) | $8.27M | +7.9% | -12.1% | 6.8% | |
Competitors are the stored peer set for KEQU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Apr 2021 | FY2022 Apr 2022 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 |
|---|---|---|---|---|---|
| Revenue | 147.47M | 168.87M | 219.49M | 203.76M | 240.47M |
| Cost of Revenue | 123.48M | 144.65M | 183.91M | 151.7M | 171.62M |
| Gross Profit | 23.99M | 24.22M | 35.59M | 52.05M | 68.86M |
| Gross Margin | 16.3% | 14.3% | 16.2% | 25.5% | 28.6% |
| Research & Development | 1.41M | 990K | 1.01M | 920K | 0 |
| Selling, General & Admin | 26.46M | 26.8M | 29.93M | 37.95M | 51.1M |
| Operating Expenses | 25.31M | 26.83M | 30.22M | 33.77M | 51.1M |
| Depreciation & Amortization | 2.69M | 2.77M | 2.87M | 3.13M | 4.76M |
| EBITDA | 459K | 916K | 8.16M | 18.04M | 22.76M |
| EBITDA Margin | 0.3% | 0.5% | 3.7% | 8.9% | 9.5% |
| Operating Income | (1.32M) | (2.61M) | 3.63M | 18.28M | 17.76M |
| Operating Margin | -0.9% | -1.5% | 1.7% | 9.0% | 7.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 389K | 632K | 1.73M | 1.8M | 3.21M |
| Other Income / Expenses | (1.3M) | 123K | (866K) | (5.16M) | (2.97M) |
| Income Before Tax | (2.62M) | (2.49M) | 4.5M | 13.12M | 14.79M |
| Pre-Tax Margin | -1.8% | -1.5% | 2.0% | 6.4% | 6.1% |
| Income Tax Expense | 990K | 3.52M | 3.14M | (5.94M) | 3.2M |
| Net Income | (3.61M) | (6M) | 1.36M | 18.75M | 11.41M |
| Net Margin | -2.4% | -3.6% | 0.6% | 9.2% | 4.7% |
| EPS (Basic) | (1.31) | (2.15) | 0.48 | 6.51 | 3.98 |
| EPS (Diluted) | (1.31) | (2.15) | 0.47 | 6.38 | 3.83 |
| Weighted Avg Shares | 2.76M | 2.79M | 2.82M | 2.88M | 2.86M |
| Weighted Avg Shares (Diluted) | 2.76M | 2.79M | 2.9M | 2.94M | 2.98M |
Kewaunee Scientific Corporation
NASDAQ:KEQU
Intrinsic Alpha fair value
Locked
Current Price
$34.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.